NYVAC: A highly attenuated strain of vaccinia virus

Virology

Volumn 188, Issue 1, 1992, Pages 217-232

  Tartaglia, James ^a   Perkus, Marion E ^a   Taylor, Jill ^a   Norton, Elizabeth K ^a   Audonnet, Jean Christophe ^a   Cox, William I ^a   Davis, Stephen W ^a   Van Der Hoeven, Johanna ^a   Meignier, Bernard ^b   Riviere, Michel ^c   Languet, Bernard ^c   Paoletti, Enzo ^a  

^a Virogenetics Corporation   (United States)

^b Pasteur Merieux Connaught   (France)

^c Laboratoire IFFA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4B; RIBONUCLEOTIDE REDUCTASE; SECRETORY PROTEIN; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE INSERTION; HUMAN; HUMAN CELL; LD 50; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VACCINIA VIRUS; VIRUS ATTENUATION; VIRUS ISOLATION; VIRUS MUTANT; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMAL; CELL LINE; GENE EXPRESSION; GENOME, VIRAL; HUMAN; MICE; OPEN READING FRAMES; PRECIPITIN TESTS; RABBITS; RABIES VIRUS; RESTRICTION MAPPING; VACCINATION; VACCINES, ATTENUATED; VACCINIA VIRUS; VIRAL ENVELOPE PROTEINS; VIRULENCE; VIRUS REPLICATION;

ANIMALIA; AVES; AVIPOX VIRUS; MUS MUSCULUS; ORYCTOLAGUS CUNICULUS; VACCINIA; VACCINIA VIRUS;

EID: 0026691693     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/0042-6822(92)90752-B     Document Type: Article

References (65)

1. Vaccinia virus-encoded eIF-2α homolog abrogates the antiviral effect of interferon
2. The smallpox story: Life and death of an old disease
3. Comparative observations on poxviruses of invertebrates and vertebrates
4. One hundred base pairs of 5′ flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription
5. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype
6. Deletion of the vaccinia virus growth factor gene reduces virus virulence
7. Poxvirus pathogenesis
8. Vaccinia virus expression vector: Co-expression of β-galactosidase provides visual screening of recombinant virus plaques
9. Insertional inactivation of the large subunit of ribonucleotide reductase encoded by vaccinia virus is associated with reduced virulence in vivo
10. Reciprocity in the interactions between the poxviruses and their host cells
11. Physical change in cytoplasmic messenger ribonucleoproteins in cells treated with inhibitors of mRNA transcription
12. Direct sequencing of enzymatically amplified human genomic DNA
13. The biological characters of several strains of vaccinia, cowpox, and rabbitpox viruses
14. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression
15. Cloning and characterization of the gene encoding the major protein of the A-type inclusion body of cowpox virus
16. Comparative studies of genetic markers of some pox virus strains
17. A vaccinia virus double recombinant expressing the F and H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions
18. Localization and sequence of a vaccinia virus gene required for multiplication in human cells
19. The complete DNA sequence of vaccinia virus
20. The complete DNA sequence of vaccinia virus (Appendix)
21. Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: Characterization of an ICP6 deletion mutant
22. Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals
23. Coexpression by vaccinia virus recombinants of equine herpesvirus-1 glycoproteins gpl3 and gpl4 results in potentiated immunity
24. A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells
25. Induction of both thymidine and deoxycytidine kinase activity by herpes viruses
26. Virulence genes of poxviruses and reoviruses
27. A study on the morphological and cyto-immunological relationship between the inclusions of variola, cowpox, rabbitpox, vaccinia (variola origin) and vaccinia IHD and a consideration of the term “Guarnieri body”
28. Expression of rabies virus glycoprotein from a recombinant vaccinia virus
29. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins
30. Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da protein
31. Inhibition of the complement cascade by the major secretory protein of vaccinia virus
32. Oligonucleotide-directed double-strand break repair in plasmids of Escherichia coli. A method for site-specific mutagenesis
33. The function of the vaccinia hemagglutinin in the proteolytic activation of infectivity
34. Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus
35. Two major DNA variants present in serially propagated stocks of the WR strain of vaccinia virus
36. Construction of poxviruses as cloning vectors: Insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus
37. Vaccinia virus vectors utilizing the β-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression
38. Further studies of the infectious unit of vaccinia
39. Messenger RNAs of a strongly-expressed late gene of cowpox virus contain 5′-terminal poly(A) sequences
40. A poxvirus-derived vector that directs high levels of expression of cloned genes in mammalian cells
41. Recombinant vaccinia virus: Immunization against multiple pathogens
42. Cloning and expression of foreign genes in vaccinia virus, using a host range selection system
43. Vaccinia virus host range genes
44. Vaccinia virus as an expression vector
45. Spontaneous deletions and duplications of sequences in the genome of cowpox virus
46. Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases
47. A simple method of estimating fifty percent endpoints
48. T-cell-mediated regression of “spontaneous” and of Epstein-Barr virus-induced B-cell transformation in vitro: Studies with cyclosporin A
49. DNA sequencing with chain-terminating inhibitors
50. The NIH test for potency
51. New versatile plasmid vectors for expression of hybrid proteins coded by a cloned gene fused to IacZ gene sequences encoding an enzymatically active carboxyl-terminal portion of β-galactosidase
52. Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene
53. A cowpox virus gene required for multiplication in Chinese hamster ovary cells
54. Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs
55. DNA sequence analysis with a modified bacteriophage T7 DNA polymerase
56. Poxvirus-based vectors as vaccine candidates
57. A recombinant fowlpox virus induces protective immunity in non-avian species
58. + phenotypes of vaccinia virus recombinants after intranasal inoculation of mice
59. Efficacy studies on a canarypox-rabies recombinant virus
60. The molecular pathogenesis of poxviruses
61. Increased antibody responses to human papillomavirus type 16 Ll protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes